Accelerate Diagnostics Company Profile (NASDAQ:AXDX)

Analyst Ratings

Consensus Ratings for Accelerate Diagnostics (NASDAQ:AXDX) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $22.67 (15.35% upside)

Analysts' Ratings History for Accelerate Diagnostics (NASDAQ:AXDX)
Show:
DateFirmActionRatingPrice TargetActions
6/15/2016BTIG ResearchReiterated RatingBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Piper Jaffray Cos.Reiterated RatingOverweight$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2016JPMorgan Chase & Co.Initiated CoverageOverweight$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016William BlairReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Accelerate Diagnostics (NASDAQ:AXDX)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Accelerate Diagnostics (NASDAQ:AXDX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.31)($0.31)($0.31)
Q3 20161($0.32)($0.32)($0.32)
Q4 20161($0.33)($0.33)($0.33)
Q1 20171($0.33)($0.33)($0.33)
Q2 20171($0.33)($0.33)($0.33)
Q3 20171($0.31)($0.31)($0.31)
Q4 20171($0.31)($0.31)($0.31)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Accelerate Diagnostics (NASDAQ:AXDX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Accelerate Diagnostics (NASDAQ:AXDX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/30/2016Jack W SchulerDirectorBuy90,147$13.95$1,257,550.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2016Jack W SchulerDirectorBuy14,033$13.67$191,831.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2016Jack W SchulerDirectorBuy15,967$13.70$218,747.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2016Jack W SchulerDirectorBuy88,316$14.69$1,297,362.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Jack W SchulerDirectorBuy101,272$14.14$1,431,986.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Jack W SchulerDirectorBuy4,270$11.04$47,140.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Jack W SchulerDirectorBuy10,000$11.45$114,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Jack W SchulerDirectorBuy11,511$11.91$137,096.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Jack W SchulerDirectorBuy20,000$12.45$249,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2016Jack W SchulerDirectorBuy600,000$11.86$7,116,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/8/2016Jack W SchulerDirectorBuy20,000$12.32$246,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2016Jack W SchulerDirectorBuy7,308$12.65$92,446.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2016Jack W SchulerDirectorBuy10,000$12.98$129,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2016Jack W SchulerDirectorBuy50,100$13.09$655,809.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2016Jack W SchulerDirectorBuy20,000$13.46$269,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/21/2016Jack W SchulerDirectorBuy10,000$15.02$150,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Larry N FeinbergMajor ShareholderBuy117,647$17.00$1,999,999.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2015Jack W SchulerDirectorBuy11,899$16.81$200,022.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2015Jack W SchulerDirectorBuy52,837$16.81$888,189.97View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/22/2015Jack W SchulerDirectorBuy2,160$15.82$34,171.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/29/2015Brink Frank Jm TenDirectorBuy9,800$15.24$149,352.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2015Jack W SchulerDirectorBuy10,000$17.81$178,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2015Jack W SchulerDirectorBuy10,000$18.56$185,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/17/2015Jack W SchulerDirectorBuy11,000$21.94$241,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Matthew StrobeckDirectorBuy2,000$22.04$44,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/9/2015Jack W SchulerDirectorBuy22,584$17.18$387,993.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Jack W SchulerDirectorBuy18,000$18.93$340,740.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2014Jack W SchulerDirectorBuy2,588$16.44$42,546.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2014Jack W SchulerDirectorBuy32,411$16.67$540,291.37View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2014Jack W SchulerDirectorBuy2,900$16.79$48,691.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Larry N FeinbergMajor ShareholderBuy11,835$15.92$188,413.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Matthew StrobeckDirectorBuy20,000$16.70$334,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/16/2014Larry N FeinbergMajor ShareholderBuy20,000$21.54$430,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Jack W SchulerDirectorBuy8,698$25.70$223,538.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2014Jack W SchulerDirectorBuy10,000$26.09$260,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2014Larry N FeinbergMajor ShareholderBuy20,000$25.72$514,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Larry N FeinbergMajor ShareholderBuy297,618$16.80$4,999,982.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2014Larry N FeinbergMajor ShareholderBuy8,554$24.78$211,968.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2014Larry N FeinbergMajor ShareholderBuy16,307$13.09$213,458.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/31/2013Larry N FeinbergMajor ShareholderBuy84,081$12.29$1,033,355.49View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2013Larry N FeinbergMajor ShareholderBuy10,000$12.95$129,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/30/2013Larry N FeinbergMajor ShareholderBuy16,001$9.76$156,169.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2013Larry N FeinbergMajor ShareholderBuy158,445$9.80$1,552,761.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013Jack W SchulerDirectorBuy78,494$7.88$618,532.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Jack W SchulerDirectorBuy413,090$8.04$3,321,243.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Larry N FeinbergMajor ShareholderBuy36,814$7.24$266,533.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/9/2013Larry N FeinbergMajor ShareholderBuy35,168$7.30$256,726.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2013Larry N FeinbergMajor ShareholderBuy114,250$8.00$914,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2013Larry N FeinbergMajor ShareholderBuy7,175$8.41$60,341.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013Larry N FeinbergMajor ShareholderBuy45,508$8.33$379,081.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Accelerate Diagnostics (NASDAQ:AXDX)
DateHeadline
07/26/16 10:45 AMETF’s with exposure to Accelerate Diagnostics, Inc. : July 26, 2016 -
07/22/16 10:52 AMAccelerate Diagnostics Inc. : Accelerate Diagnostics to Report Second-Quarter 2016 Results on August 8 - The Wall Street Transcript
07/22/16 07:38 AMAccelerate Diagnostics to Report Second-Quarter 2016 Results on August 8 - [at noodls] - 2fc524b6-a90b-4dd1-a954-9dc6be7cbfa9.pdf July 22, 2016 TUCSON, Ariz., July 22, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report second- quarter 2016 financial results ...
07/21/16 08:35 AMAccelerate Diagnostics Incorporated (NASDAQ:AXDX) Short Interest Increased By 2.3% - Consumer Eagle
07/19/16 02:42 PMShare Performance Summary for: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph
07/18/16 02:45 PMToday's Hot List: Accelerate Diagnostics, Inc. (NASDAQ:AXDX), Chanticleer (NASDAQ:HOTR), Bluerock Residential ... - KC Register
07/18/16 02:45 PMAccelerate Diagnostics Inc Stock Faces Higher Risks Forward After Forming Bearish Double Bottom - Press Telegraph
07/17/16 02:36 PMStock in Positive Territory for the Quarter: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Engelwood Daily
07/16/16 09:04 AMAccelerate Diagnostics Inc Realized Volatility Hits Extreme Level - CML News
07/15/16 01:17 PM4 Stocks To Watch: ACIA, AXDX, LCI, XNCR
07/14/16 11:36 AMAccelerate Diagnostics Inc. (AXDX) is Trading Higher on Unusual Volume for July 12 - Equities.com
07/13/16 10:49 AMAccelerate Diagnostics Incorporated (NASDAQ:AXDX) Shorted Shares Increased By 5.45% - Consumer Eagle
07/13/16 05:02 AMACCELERATE DIAGNOSTICS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
07/11/16 07:30 AMStock on the Rise for the Quarter: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Engelwood Daily
07/11/16 07:30 AMStock Performance Rundown on: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph
07/11/16 04:23 AMAccelerate Diagnostics Submits De Novo Request to FDA for Accelerate Pheno™ System and Accelerate PhenoTest™ BC kit - [at noodls] - 7a8ad1d2-779e-4e27-9e8a-2f51c3e14302.pdf July 11, 2016 TUCSON, Ariz., July 11, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. ("Accelerate") announced today the submission of a De Novo ...
07/11/16 04:12 AM5:12 am Accelerate Diagnostics submits De Novo request for its Accelerate Pheno system and Accelerate PhenoTest for Evaluation of Automatic Class III Designation to the FDA -
07/10/16 07:27 AMAccelerate Diagnostics Incorporated (NASDAQ:AXDX) Sellers Increased By 5.45% Their Shorts - Engelwood Daily
07/08/16 07:50 PMAccelerate Diagnostics Inc (NASDAQ:AXDX) Institutional Investors Sentiment Change - Engelwood Daily
07/07/16 02:43 PMInsiders Increasing Positions in: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph
07/06/16 07:29 AMShares Providing Results This Month for Investors: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Telanagana Press
07/06/16 07:29 AMAccelerate Diagnostics Inc. (AXDX) Jumps 12.72% on July 04 - Equities.com
07/05/16 02:40 PMShare Performance Recap for: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Press Telegraph
07/04/16 02:39 PMBroker Outlook For The Week Ahead Accelerate Diagnostics, Inc. (AXDX) - Fiscal Standard
07/04/16 07:33 AMFriday’s Stock Recap: The Big Movers
07/02/16 10:22 AMAccelerate Diagnostics Inc. (AXDX) Jumps 12.72% on July 01 - Equities.com
07/01/16 02:43 PMTracking Stock Volatility for: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Engelwood Daily
06/30/16 10:32 AMNewly released market study: Accelerate Diagnostics, Inc. (AXDX) - Financial and Strategic SWOT Analysis Review
06/29/16 10:52 AMWhat's Accelerate Diagnostics Inc Downside After Today's Huge Decline? - Press Telegraph
06/29/16 10:52 AMWatching Stock Volatility for: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Engelwood Daily
06/29/16 10:52 AMAccelerate Diagnostics, Inc. (AXDX) Current Analyst Ratings - Fiscal Standard
06/27/16 02:20 PMGenMark, T2 And Accelerate Diagnostics Impress Analysts At Microbiology Forum - Benzinga
06/27/16 07:24 AMAccelerate Diagnostics, Inc. (AXDX) Broker Price Targets For The Coming Week - Fiscal Standard
06/25/16 02:41 PMAccelerate Diagnostics Incorporated (NASDAQ:AXDX) Shorted Shares Increased 5.45% After Market Selling - Engelwood Daily
06/24/16 07:51 PMNew Broker Ratings For Accelerate Diagnostics, Inc. (AXDX) - FTSE News
06/24/16 04:24 PMETF’s with exposure to Accelerate Diagnostics, Inc. : June 24, 2016 -
06/24/16 07:23 AMAccelerate Diagnostics, Inc. (AXDX) Updated Price Targets - FTSE News
06/18/16 07:25 AMAccelerate Diagnostics Inc. (AXDX) is Trading Lower on Unusual Volume for June 16 - Equities.com
06/16/16 02:43 PMAccelerate Diagnostics Inc. (NASDAQ:AXDX) announced the completion of clinical data collection - Inside Trade
06/15/16 07:32 AMAccelerate Diagnostics Inc. (AXDX) Drops 7.46% on June 13 - Equities.com
06/14/16 07:29 PMAccelerate Diagnostics Completes Clinical Data Collection, Will Present Data at the William Blair 36th Annual Growth Stock Conference - [at noodls] - 7ff0a305-b1f2-408c-abd9-94d79f8a44f1.pdf June 14, 2016 TUCSON, Ariz., June 14, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. ("Accelerate") announced today the completion of clinical ...
06/09/16 02:42 PMAccelerate Diagnostics, Inc. (NasdaqCM:AXDX) Fundamental Star Rating Report - CML News
06/08/16 11:12 AMACCELERATE DIAGNOSTICS INC. (NASDAQ:AXDX) Financial Condition Compared to S&P 500 - CML News
06/07/16 06:28 PMAccelerate Diagnostics to Present at the 36th Annual Growth Stock Conference - [at noodls] - 5b580007-aa63-4c9a-aa1c-003585fcbd01.pdf June 7, 2016 TUCSON, Ariz., June 07, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren, the company's president and chief ...
06/03/16 02:46 PMAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Stock Update & Estimates - Stock Tick Tock
06/03/16 02:46 PMNews Sentiment For Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Investor Newswire
06/03/16 02:10 PMETF’s with exposure to Accelerate Diagnostics, Inc. : June 3, 2016 -
06/01/16 11:08 AMAccelerate Diagnostics, Inc. (AXDX) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Accelerate Diagnostics, Inc. (AXDX) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Accelerate Diagnostics, Inc. (AXDX). The latest reports which are currently in issue on Wednesday 1st of June state 0 analysts have a rating of “strong buy”, 0 analysts ...and more »
05/28/16 12:35 AMAccelerate Diagnostics Inc (AXDX) Drops 6.39% on May 26 - Equities.com - share market updates (press release)Accelerate Diagnostics Inc (AXDX) Drops 6.39% on May 26Equities.comAccelerate Diagnostics Inc (AXDX) was one of the Russell 2000's biggest losers for Thursday May 26 as the stock slid 6.39% to $12.30, a loss of $-0.84 per share. Starting at an opening price of $13.16 a share, the stock traded between $12.15 and $13.16 ...Accelerate Diagnostics, Inc. (AXDX) Updated Analyst CoverageRisers & FallersLatest Analyst Ratings For Accelerate Diagnostics, Inc. (AXDX)Share Trading NewsAccelerate Diagnostics, Inc. (NASDAQ:AXDX) Quarterly EPS From Continuing Operations Stands At $-0.2944Equities Focusshare market updates (press release) -The Post -Wall Street Hints and Newsall 7 news articles »
05/26/16 07:07 AMAccelerate Diagnostics, Inc. breached its 50 day moving average in a Bullish Manner : AXDX-US : May 26, 2016 -

Social

About Accelerate Diagnostics

Accelerate Diagnostics logoAccelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that improve patient outcomes and lower healthcare costs through the diagnosis of serious infections. The Company's technology platform is built to address these challenges by delivering testing of infectious pathogens in various patient sample types. The Company is focused on the development of a rapid diagnostic platform, the Accelerate ID/AST System (ID/AST System or Accelerate ID/AST System), intended for the diagnosis of infectious pathogens. The ID/AST System utilizes genotypic technology to identify (ID) infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. The ID/AST System features walk-away automation and consists of a fixed instrument and single-use test kit.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AXDX
  • CUSIP:
Key Metrics:
  • Previous Close: $20.09
  • 50 Day Moving Average: $17.11
  • 200 Day Moving Average: $14.17
  • P/E Ratio: N/A
  • P/E Growth: -0.53
  • Market Cap: $1.01B
  • Beta: 1.23
  • Current Year EPS Consensus Estimate: $-1.27 EPS
  • Next Year EPS Consensus Estimate: $-1.36 EPS
Additional Links:
Accelerate Diagnostics (NASDAQ:AXDX) Chart for Saturday, July, 30, 2016